Lucira Health

Acquired

Next generation infectious disease test kits

Public · Emeryville, United States · $52.0M raised

Employees
11–50
Total Funding
$52.0M
Last Round
$15.0M Series BAug 2019
Rounds
4
Type
Public

About

Diassess Inc. is revolutionizing the way infectious diseases are prevented, diagnosed, and monitored by developing the tools necessary to empower people to become knowledgeable about their health. We produce inexpensive, disposable health diagnostic hardware that transforms any smartphone into a portable, real-time health-monitoring device for rapid, accessible, multiplexed analysis of bodily fluids anywhere in the world.

Summary

Lucira Health is a Diagnostics company based in Emeryville, United States. It has raised $52.0M in total across 4 rounds, most recently a $15.0M Series B round in Aug 2019. Investors include Biomedical Advanced Research and Development Authority (BARDA), Seraph Group and Pfizer Ventures.

Tech & App Stack

3 technologies & apps tracked

Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.

Sign up to view the funding chart

Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.

Funding History

AcquisitionApr 2023
$36.4M

Sign up to see all 7 rounds

Full funding history, per-round amounts, and investor participation.

Investors

Similar Companies